Related references
Note: Only part of the references are listed.Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment
Ayman El-Sayed et al.
AAPS JOURNAL (2009)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Drug Delivery by an Enzyme-Mediated Cyclization of a Lipid Prodrug with Unique Bilayer-Formation Properties
Lars Linderoth et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
D. R. Richardson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Release of Liposomal Contents by Cell-Secreted Matrix Metalloproteinase-9
Jayati Banerjee et al.
BIOCONJUGATE CHEMISTRY (2009)
Targeting the Urokinase Plasminogen Activator Receptor with Synthetic Self-Assembly Nanoparticles
Ming Wang et al.
BIOCONJUGATE CHEMISTRY (2009)
Folate Receptor Targeted Bimodal Liposomes for Tumor Magnetic Resonance Imaging
Nazila Kamaly et al.
BIOCONJUGATE CHEMISTRY (2009)
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors
Kathleen M. McNeeley et al.
BIOMATERIALS (2009)
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
Frederic Heitz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Ian F. Robey et al.
CANCER RESEARCH (2009)
Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
TamerA. El Bayoumil et al.
CLINICAL CANCER RESEARCH (2009)
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
XueMing Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Avi Schroeder et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Synthesis and Biophysical Characterization of Chlorambucil Anticancer Ether Lipid Prodrugs
Palle J. Pedersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Tumor-Specific Anti-Nucleosome Antibody Improves Therapeutic Efficacy of Doxorubicin-Loaded Long-Circulating Liposomes against Primary and Metastatic Tumor in Mice
Tamer A. ElBayoumi et al.
MOLECULAR PHARMACEUTICS (2009)
Tumor-vascular interactions and tumor dormancy
George N. Naumov et al.
APMIS (2008)
The neovasculature homing motif NGR: more than meets the eye
Angelo Corti et al.
BLOOD (2008)
Prodrug strategies in anticancer chemotherapy
Felix Kratz et al.
CHEMMEDCHEM (2008)
Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice
Atsushi Yamada et al.
CLINICAL CANCER RESEARCH (2008)
Antibody-modified liposomes for cancer chemotherapy
Vladimir Torchilin
EXPERT OPINION ON DRUG DELIVERY (2008)
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome
Ryo Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape
Ayman El-Sayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab' fragments and single chain Fv
Wilson W. K. Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9
Adekunle I. Elegbede et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sheddable coatings for long-circulating nanoparticles
Birgit Romberg et al.
PHARMACEUTICAL RESEARCH (2008)
Cell-penetrating peptides for drug delivery across membrane barriers
Camilla Foged et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Cell penetrating peptides: Intracellular pathways and pharmaceutical perspectives
Leena N. Patel et al.
PHARMACEUTICAL RESEARCH (2007)
Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines
Tamer A. Elbayoumi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Phospholipase A2 as targets for anti-cancer drugs
Brian S. Cummings
BIOCHEMICAL PHARMACOLOGY (2007)
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hiroto Hatakeyama et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells
Tomotaka Kobayashi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action
Samuel Zalipsky et al.
JOURNAL OF DRUG TARGETING (2007)
Enhanced transfection of tumor cells in vivo using Smart pH-sensitive TAT-modified pegylated liposomes
Amit A. Kale et al.
JOURNAL OF DRUG TARGETING (2007)
Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells
Yashwant Gupta et al.
JOURNAL OF DRUG TARGETING (2007)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H. Hatakeyama et al.
GENE THERAPY (2007)
Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production
S. Moein Moghimi et al.
FASEB JOURNAL (2006)
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy
Fabio Pastorino et al.
CANCER RESEARCH (2006)
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
Justin M. Saul et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Activation of interfacial enzymes at membrane surfaces
Ole G. Mouritsen et al.
JOURNAL OF PHYSICS-CONDENSED MATTER (2006)
SMART drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers
R. M. Sawant et al.
BIOCONJUGATE CHEMISTRY (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
Chunling Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting
T Terada et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes
AA Gabizon et al.
CLINICAL CANCER RESEARCH (2006)
Mechanistic aspects of CPP-mediated intracellular drug delivery:: Relevance of CPP self-assembly
Silvia Pujals et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression
IA Khalil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Exploiting the enhanced permeability and retention effect for tumor targeting
Arun K. Iyer et al.
DRUG DISCOVERY TODAY (2006)
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations
MJW Johnston et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
K Temming et al.
DRUG RESISTANCE UPDATES (2005)
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
KM Laginha et al.
CLINICAL CANCER RESEARCH (2005)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
K Laginha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
N Parker et al.
ANALYTICAL BIOCHEMISTRY (2005)
Gelatinases (MMP-2 and-9) and their natural inhibitors as prognostic indicators in solid cancers
T Turpeenniemi-Hujanen
BIOCHIMIE (2005)
Uncorking of liposomes by matrix metalloproteinase-9
NR Sarkar et al.
CHEMICAL COMMUNICATIONS (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells
P Hölig et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy
H Elnakat et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery
WJ Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077B103) in a preclinical tumor model of melanoma
WC Zamboni et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs
TL Andresen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models
D Peer et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab′ fragments
P Sapra et al.
CLINICAL CANCER RESEARCH (2004)
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models
D Peer et al.
NEOPLASIA (2004)
Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
R Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody
AN Lukyanov et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Ligand-targeted liposomal anticancer drugs
P Sapra et al.
PROGRESS IN LIPID RESEARCH (2003)
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer:: in vivo studies
S Dagar et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Peptide and protein drug delivery to and into tumors: challenges and solutions
VP Torchilin et al.
DRUG DISCOVERY TODAY (2003)
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective targeting of cancer cells using synthetic peptides
M Shadidi et al.
DRUG RESISTANCE UPDATES (2003)
A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity
JM Metselaar et al.
BIOCONJUGATE CHEMISTRY (2003)
Enzyme and proton-activated prodrugs for a selective cancer therapy
LF Tietze et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
SY Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery
K Jorgensen et al.
FEBS LETTERS (2002)
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and TAT: A kinetic and efficacy study
YL Tseng et al.
MOLECULAR PHARMACOLOGY (2002)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial
DM Vail et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma
JZ Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats
H Takeuchi et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages
SA Johnstone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
CE Swenson et al.
BREAST (2001)
Phase I-II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
KJ Harrington et al.
ANNALS OF ONCOLOGY (2001)
Screening effect of PEG on avidin binding to liposome surface receptors
T Kaasgaard et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Liposome application: problems and prospects
Y Barenholz
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2001)
Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
AA Gabizon
CANCER INVESTIGATION (2001)
Current status of pH-sensitive liposomes in drug delivery
DC Drummond et al.
PROGRESS IN LIPID RESEARCH (2000)
Measurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chains
NV Efremova et al.
BIOCHEMISTRY (2000)
Tc-99m-PEG-liposomes for the evaluation of colitis in Crohn's disease
AH Brouwers et al.
JOURNAL OF DRUG TARGETING (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
